# Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis

> **NCT03062501** · PHASE2 · UNKNOWN · sponsor: **Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti** · enrollment: 30 (estimated)

## Conditions studied

- Anemia, Sickle Cell
- Anemia; Sickle-Cell, With Crisis

## Interventions

- **DRUG:** Hydroxyurea

## Key facts

- **NCT ID:** NCT03062501
- **Lead sponsor:** Instituto Estadual de Hematologia Arthur de Siqueira Cavalcanti
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-11
- **Primary completion:** 2017-04
- **Final completion:** 2017-07
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2017-02-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03062501

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03062501, "Hydroxyurea in the Emergency Room to Lessen Pain in Sickle Cell Crisis". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03062501. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*